A meta-analysis by the Cardiovascular Research Foundation, and published in the June 15 edition of Circulation, of 56 studies that covered 190,000 patients revealed unambiguous benefits for use of drug-eluting stents (DES) instead of bare metal stents. DES resulted in a reduction in death from no difference (meta-analysis of 22 randomized trials) to a 22% reduction [...]
In addition to bare metal, drug-eluting and absorbable stents on the market or under development for the treatment of coronary artery diseases, innovative companies have developed other types of stents to treat cardiovascular disease. These include bioactive coatings, antibody coatings, biomimetic coatings, hydrophilic coatings, titanium-nitride-oxide coatings, pericardium-covered stents, radioactive stents, synthetic graft alternatives, tissue engineered coatings, stents [...]
Angioplasty for the revascularization of blocked coronary arteries gave way in the evolution of clinical practice to the adjunctive use of bare metal coronary stents, but due to a high frequency of restenosis bare metal stents gave way to drug-eluting stents (DESs) in 2003 (J&J/CYPHER, followed in 2004 by Boston Scientific’s TAXUS, and soon followed by [...]
The global market for drug-eluting, bare and bioresorbable stents for the treatment of coronary artery disease is in a "growth and proliferation" phase, as the market for these devices is growing steadily through application to growing patient caseload, and as the number of companies with approved products or products in development multiplies. The bulk of interest [...]
Lest anyone believe that drug-eluting coronary stents have taken over the acute myocardial infarction world, a good number of companies are active in the development and marketing of bare metal stents. See a list of manufacturers below, drawn from the MedMarket Diligence Report #C245, "Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017." Aachen [...]
Most popular recent posts on "advanced medical technologies": Opportunities for coronary stent manufacturers High growth medical technologies Beyond drug-eluting and bioresorbable stents Product development trend in surgical sealants, glues, hemostats Ablation: An Energized Market bookmark to
Preliminary list of companies to be profiled in drug-eluting stent market report, listed below. I know what you’re thinking — you had no idea there were so many. Abbott Vascular AdvanSource Biomaterials Aeon Bioscience Arterial Remodeling Technologies (ART) Atrium Medical Avantec Vascular B. Braun Melsungen Bioabsorbable Therapeutics, Inc. (BTI) Biocompatibles International plc Biosensors International PTE [...]
Contact:
